ActiTrexx (private company)

See something wrong or missing? Let us know
Offices:Mainz
Business model:B2B

ActiTrexx has developed a cellular therapy with activated regulatory T cells ( ATreg) to minimize the high risk of rejection after stem cell transplantation.

Investors: we tracked 4 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 4.18M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to ActiTrexx

Name Criteria
Norway APIM Therapeutics
57%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Sano Genetics
57%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Norway SonoClear
57%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Adapttech
57%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Poland Molecule.one
57%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Clustermarket
57%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Austria Sarcura
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Switzerland Scailyte
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Denmark Synklino
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom CellulaREvolution
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Top